High prevalence of BK Polyomavirus Sequences in Human Papillomavirus-16-Positive Precancerous Cervical Lesions

Journal of Medical Virology

Volumn 83, Issue 10, 2011, Pages 1770-1776

  Comar, Manola ^a   Bonifacio, Daniela ^a   Zanconati, Fabrizio ^a   Di Napoli, Michela ^a   Isidoro, Erica ^a   Martini, Fernanda ^b   Torelli, Lucio ^a   Tognon, Mauro ^b  

^a UNIVERSITY OF TRIESTE   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

Author keywords

Cervical lesion; Human papillomavirus; Polyomavirus; Viral load

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; BK VIRUS; CANCER GRADING; CELL TRANSFORMATION; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; GENETIC ANALYSIS; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; JC VIRUS; MAJOR CLINICAL STUDY; POINT MUTATION; POLYMERASE CHAIN REACTION; PRECANCER; PRECANCEROUS CERVICAL LESION;

ADULT; BK VIRUS; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; DNA, VIRAL; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMAN PAPILLOMAVIRUS 31; HUMANS; JC VIRUS; MIDDLE AGED; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; PRECANCEROUS CONDITIONS; SIMIAN VIRUS 40; UTERINE CERVICAL DISEASES;

BK POLYOMAVIRUS; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS - 16; HUMAN PAPILLOMAVIRUS TYPE 16; JC POLYOMAVIRUS; POLYOMAVIRUS; SIMIAN VIRUS 40;

EID: 80051590452     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.22184     Document Type: Article

References (45)

1. Balis V, Sourvinos G, Soulitzis N, Giannikaki E, Sofras F, Spandidos DA. 2007. Prevalence of BK virus and human papillomavirus in human prostate cancer. Int J Biol Markers 22: 245-251.
2. Barbanti-Brodano G, Martini F, De Mattei M, Lazzarin L, Corallini A, Tognon M. 1998. BK and JC human polyomaviruses and simian virus 40: Natural history of infection in humans, experimental oncogenicity, and association with human tumors. Adv Virus Res 50: 69-99.
3. Barbanti-Brodano G, Sabbioni S, Martini F, Negrini M, Corallini A, Tognon M. 2004. Simian virus 40 infection in humans and association with human diseases: Results and hypotheses. Virology 318: 1-9.
4. Barbanti-Brodano G, Sabbioni S, Martini F, Negrini M, Corallini A, Tognon M. 2006. BK virus, JC virus and Simian Virus 40 infection in humans, and association with human tumors. Adv Exp Med Biol 577: 319-341.
5. Bosch FX, Burchell AN, Schiffman M, Giuliano AR, de Sanjose S, Bruni L, Tortolero-Luna G, Kjaer SK, Muñoz N. 2008. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine 26: K1-K16.
6. Clifford GM, Smith JS, Plummer M, Muñoz N, Franceschi S. 2003. Human papillomavirus types in invasive cervical cancer worldwide: A meta-analysis. Br J Cancer 88: 63-73.
7. Comar M, Dal Molin G, D'Agaro P, Crocè SL, Tiribelli C, Campello C. 2006. HBV, HCV, and TTV detection by in situ polymerase chain reaction could reveal occult infection in hepatocellular carcinoma: Comparison with blood markers. J Clin Pathol 59: 526-529.
8. Comar M, Rizzardi C, De Zotti R, Melato M, Bovenzi M, Butel JS, Campello C. 2007. SV40 multiple tissue infection and asbestos exposure in a hyperendemic area for malignant mesothelioma. Cancer Res 67: 8456-8459.
9. Comar M, Spano A, Canova S, Bogoni S, Marziliano N, Cernigoi E, Boniotto M, Amoroso A, Parodi S, Campello C, Crovella S. 2001. Direct in situ PCR allows rapid and sensitive detection of high risk human papillomavirus in cytologic specimens and formalin-fixed paraffin tissues by fluorescent labelling. Int J Oncol 18: 181-185.
10. Comar M, Zanotta N, Bovenzi M, Campello C. 2010. JCV/BKV and SV40 viral load in lymphoid tissues of young immunocompetent children from an area of north-east Italy. J Med Virol 82: 1236-1240.
11. Das D, Wojno K, Imperiale MJ. 2008. BK virus as a cofactor in the etiology of prostate cancer in its early stages. J Virol 82: 2705-2714.
12. De Mattei M, Martini F, Corallini A, Gerosa M, Scotlandi K, Carinci P, Barbanti-Brodano G, Tognon M. 1995. High incidence of BK virus large-T-antigen-coding sequences in normal human tissues and tumors of different histotypes. Int J Cancer 61: 756-760.
13. Di Maio D, Liao. JB. 2006. Human papillomaviruses and cervical cancer. Adv Virus Res 66: 125-159.
14. Ewald D, Li M, Efrat S, Auer G, Wall RJ, Furth PA, Hennighausen L. 1996. Time-sensitive reversal of hyperplasia in transgenic mice expressing SV40 T antigen. Science 273: 1384-1386.
15. Franceschi S. 2005. The IARC commitment to cancer prevention: The example of papillomavirus and cervical cancer recent results. Cancer Res 166: 277-297.
16. Gjoerup O, Chang Y. 2010. Update on human polyomaviruses and cancer. Adv Cancer Res 106: 1-51.
17. Hanahan D, Weinberg RA. 2000. The hallmarks of cancer. Cell 100: 57-70.
18. Hasan UA, Bates E, Takeshita F, Biliato A, Accardi R, Bouvard V, Mansour M, Vincent I, Gissmann L, Iftner T, Sideri M, Stubenrauch F, Tommasino M. 2007. TLR9 expression and function is abolished by the cervical cancer-associated human papillomavirus type 16. J Immunol 178: 3186-3197.
19. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. 2007. Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum 90: 1-636.
20. Imperiale MJ. 2000. The human polyomaviruses, BKV and JCV: Molecular pathogenesis of acute disease and potential role in cancer. Virology 267: 1-7.
21. Javier RT, Butel JS. 2008. The history of tumor virology. Cancer Res 68: 7693-7706.
22. Jiang M, Abend JR, Johnson SF, Imperiale MJ. 2009. The role of polyomaviruses in human disease. Virology 384: 266-273.
23. Martin D, Gutkind JS. 2008. Human tumor-associated viruses and new insights into the molecular mechanisms of cancer. Oncogene Suppl. 2: S31-S42.
24. Martini F, Iaccheri L, Lazzarin L, Carinci P, Corallini A, Gerosa M, Tognon M. 1996. SV40 early region and large T antigen in human brain tumors, peripheral blood cells, and sperm fluids from healthy individuals. Cancer Res 56: 4820-4826.
25. Martini F, Iaccheri L, Martinelli M, Martinello R, Grandi E, Mollica G, Tognon M. 2004. Papilloma and polyoma DNA tumor virus sequences in female genital tumors. Cancer Invest 22: 697-705.
26. McCabe MT, Low JA, Imperiale MJ, Day ML. 2006. Human polyomavirus BKV transcriptionally activates DNA methyltransferase 1 through the pRb/E2F pathway. Oncogene 25: 2727-2735.
27. McNees AL, White ZS, Zanwar P, Vilchez RA, Butel JS. 2005. Specific and quantitative detection of human polyomaviruses BKV, JCV, and SV40 by real time PCR. J Clin Virol 34: 52-62.
28. Monini P, Rotola A, Di Luca D, De Lellis L, Chiari E, Corallini A, Cassai E. 1995. DNA rearrangements impairing BK virus productive infection in urinary tract tumours. Virology 214: 273-279.
29. Moody CA, Laimins LA. 2010. Human papillomavirus oncoproteins: Pathways to transformation. Nat Rev Cancer 10: 550-560.
30. Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, Snijders PJ, Meijer CJ, International for Agency Research on Cancer Multicenter Cervical Cancer Study Group. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348: 518-527.
31. Neuveut C, Wei Y, Buendia MA. 2010. Mechanisms of HBV-related hepatocarcinogenesis. J Hepatol 52: 594-604.
32. Niller HH, Wolf H, Minarovits J. 2009. Epigenetic dysregulation of the host cell genome in Epstein-Barr virus-associated neoplasia. Semin Cancer Biol 19: 158-164.
33. Nobbenhuis MA, Helmerhorst TJ, van den Brule AJ, Rozendaal L, Voorhorst FJ, Bezemer PD, Verheijen RH, Meijer CJ. 2001. Cytological regression and clearance of high-risk human papillomavirus in women with an abnormal cervical smear. Lancet 358: 1782-1783.
34. Pancaldi C, Balatti V, Guaschino R, Vaniglia F, Corallini A, Martini F, Mutti L, Tognon M. 2009. Simian virus 40 sequences in blood specimens from healthy individuals of Casale Monferrato, an industrial town with a history of asbestos pollution. J Infect 58: 53-60.
35. Pancaldi C, Corazzari V, Maniero S, Mazzoni E, Comar M, Martini F, Tognon M. 2011. Merkel cell polyomavirus DNA sequences in the buffy coats of healthy blood donors. Blood 117: 7099-7101.
36. Ricciardiello L, Baglioni C, Giovannini M, Pariali G, Cenacchi A, Ripalti MP, Landini H, Sawa K, Nagashima RJ, Frisque A, Goel CR, Boland M, Tognon M, Roda E, Bazzoli F. 2003. Induction of chromosomal instability in colonic cells by the human polyomavirus JC virus. Cancer Res 63: 7256-7262.
37. Rodríguez AC, Schiffman M, Herrero R, Wacholder S, Hildesheim A, Castle PE, Solomon D, Burk R, Proyecto Epidemiológico Guanacaste Group. 2008. Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections. J Natl Cancer Inst 100: 513-517.
38. Saundh BK, Tibble S, Baker R, Sasnauskas K, Harris M, Hale A. 2010. Different patterns of BK and JC polyomavirus reactivation following renal transplantation. J Clin Pathol 63: 714-718.
39. Schlecht NF, Kulaga S, Robitaille J, Ferreira S, Santos M, Miyamura RA, Duarte-Franco E, Rohan TE, Ferenczy A, Villa LL, Franco EL. 2001. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA 286: 3106-3114.
40. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M. 2002. The 2001 Bethesda System: Terminology for reporting results of cervical cytology. JAMA 287: 2114-2119.
41. Tognon M, Corallini A, Martini F, Negrini M, Barbanti-Brodano G. 2003. Oncogenic transformation by BK virus and association with human tumours. Oncogene 22: 5192-5200.
42. Trabanelli A, Corallini R, Gruppioni A, Sensi A, Bonfatti D, Campioni M, Merlin N, Calza L, Barbanti-Brodano G. 1998. Chromosomal aberrations induced by BK virus T antigen in human fibroblasts. Virology 243: 492-496.
43. Vanchiere JA, White ZS, Butel JS. 2005. Detection of BK virus and simian virus 40 in the urine of healthy children. J Med Virol 75: 447-454.
44. zur Hausen H. 2000. Papillomaviruses causing cancer: Evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 92: 690-698.
45. zur Hausen H. 2009. Papillomaviruses in the causation of human cancers-A brief historical account. Virology 384: 260-265.